{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:17:43Z","timestamp":1789777063205,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032148","name":"Biohaven Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaac.2025.01.001","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T20:01:17Z","timestamp":1736452877000},"page":"775-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Systematic Review and Meta-Analysis of Individual Participant Data: Randomized, Placebo-Controlled Trials of Selective Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-6146","authenticated-orcid":false,"given":"Sem E.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9485-8037","authenticated-orcid":false,"given":"Anthonius","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-8745","authenticated-orcid":false,"given":"Bram W.C.","family":"Storosum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5751-265X","authenticated-orcid":false,"given":"Taina K.","family":"Mattila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4609-3753","authenticated-orcid":false,"given":"Marisa J.","family":"Niemeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-4156","authenticated-orcid":false,"given":"Daniel A.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3191-3844","authenticated-orcid":false,"given":"Damiaan","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6475-902X","authenticated-orcid":false,"given":"Jasper B.","family":"Zantvoord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaac.2025.01.001_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00787-021-01775-w","article-title":"Quality of life in pediatric patients with obsessive-compulsive disorder during and 3 years after stepped-care treatment","volume":"31","author":"Jensen","year":"2022","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.001_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1192\/bjp.179.4.324","article-title":"Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health","volume":"179","author":"Heyman","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.001_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.psc.2006.02.012","article-title":"Obsessive-compulsive and spectrum disorders in children and adolescents","volume":"29","author":"Geller","year":"2006","journal-title":"Psychiatr Clin North Am"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.001_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00004583-199511000-00008","article-title":"Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors","volume":"34","author":"Douglass","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.001_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4321\/S0213-61632014000300006","article-title":"A 7 year follow-up of children and adolescents with obsessive-compulsive disorder: an analysis of predictive factors in a clinical prospective study","volume":"28","author":"Becker","year":"2014","journal-title":"Eur J Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.001_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1192\/bjp.bp.109.075317","article-title":"Long-term outcomes of obsessive-compulsive disorder: follow-up of 142 children and adolescents","volume":"197","author":"Micali","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"51","author":"Geller","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.001_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/jcpp.13934","article-title":"Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis","volume":"65","author":"Cervin","year":"2024","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.001_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fpsyt.2019.00523","article-title":"The effectiveness of selective serotonin reuptake inhibitors for treatment of obsessive-compulsive disorder in adolescents and children: a systematic review and meta-analysis","volume":"10","author":"Kotapati","year":"2019","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.001_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaac.2016.07.768","article-title":"Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive-compulsive disorder","volume":"55","author":"Varigonda","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.001_bib11","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1176\/appi.ajp.160.11.1919","article-title":"Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder","volume":"160","author":"Geller","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.001_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.678538","article-title":"Developmental considerations in obsessive compulsive disorder: Comparing pediatric and adult-onset cases","volume":"12","author":"Geller","year":"2021","journal-title":"Front Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.001_bib13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.janxdis.2007.10.003","article-title":"Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD)","volume":"22","author":"Ivarsson","year":"2008","journal-title":"J Anxiety Disord"},{"issue":"8","key":"10.1016\/j.jaac.2025.01.001_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.001_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaac.2015.01.011","article-title":"Assessment and management of treatment-refractory obsessive-compulsive disorder in children","volume":"54","author":"Bloch","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.001_bib16","article-title":"Pharmacotherapy for anxiety disorders in children and adolescents","author":"Ipser","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jaac.2025.01.001_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/CHI.0b013e3181799ebd","article-title":"Predictors of treatment response in pediatric obsessive-compulsive disorder","volume":"47","author":"Ginsburg","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.001_bib18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaac.2010.06.013","article-title":"Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I)","volume":"49","author":"Garcia","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.001_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2006.09.035","article-title":"Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder","volume":"61","author":"March","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.001_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jech.54.5.326","article-title":"The ecological fallacy strikes back","volume":"54","author":"Pearce","year":"2000","journal-title":"J Epidemiol Commun Health"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.001_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaac.2021.02.024","article-title":"An individual participant data meta-analysis: behavioral treatments for children and adolescents with attention-deficit\/hyperactivity disorder","volume":"61","author":"Groenman","year":"2022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.001_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaac.2018.01.019","article-title":"Meta-analyses in child and adolescent psychiatry: getting closer to clinical practice","volume":"57","author":"Cortese","year":"2018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"16","key":"10.1016\/j.jaac.2025.01.001_bib23","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for a Systematic Review and Meta-Analysis of individual participant data: the PRISMA-IPD statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2025.01.001_bib24","series-title":"Guideline on Clinical Investigation of Medicinal Products for the Treatment of Obsessive Compulsive Disorder","year":"2005"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.001_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children\u2019s Yale-Brown Obsessive Compulsive Scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaac.2018.05.029","article-title":"Development and psychometric evaluation of the Children\u2019s Yale-Brown Obsessive-Compulsive Scale Second Edition","volume":"58","author":"Storch","year":"2019","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.001_bib27","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.jaac.2025.01.001_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2023-300951","article-title":"Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysis of randomised, placebo-controlled trials","volume":"27","author":"Cohen","year":"2024","journal-title":"BMJ Ment Health"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.001_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1503\/jpn.150268","article-title":"Adolescence as a unique developmental period","volume":"40","author":"Jaworska","year":"2015","journal-title":"J Psychiatry Neurosci"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.001_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.001_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/sim.7141","article-title":"Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ","volume":"36","author":"Burke","year":"2017","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.001_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jrsm.1661","article-title":"Two-stage or not two-stage? That is the question for IPD meta-analysis projects","volume":"14","author":"Riley","year":"2023","journal-title":"Res Synth Methods"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/wps.20299","article-title":"Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder","volume":"15","author":"Mataix-Cols","year":"2016","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.001_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/wps.20984","article-title":"Empirical severity benchmarks for obsessive-compulsive disorder across the lifespan","volume":"21","author":"Cervin","year":"2022","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.001_bib36","series-title":"R: A language and environment for statistical computing","year":"2022"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.001_bib37","first-page":"160","article-title":"ggplot2: Elegant Graphics for Data Analysis","volume":"17","author":"Villanueva","year":"2019","journal-title":"Measurement (Mahwah N J)"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.001_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jaac.2025.01.001_bib39","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.001_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1037\/a0035174","article-title":"Defining clinical severity in pediatric obsessive-compulsive disorder","volume":"26","author":"Lewin","year":"2014","journal-title":"Psychol Assess"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2024-300999","article-title":"Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitors","volume":"27","author":"Cohen","year":"2024","journal-title":"BMJ Ment Health"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib42","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2024.1768","article-title":"The minimal important difference in obsessive-compulsive disorder: an analysis of double-blind SSRI trials in adults","volume":"67","author":"Cohen","year":"2024","journal-title":"Eur Psychiatry"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.001_bib43","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaac.2019.10.013","article-title":"Antidepressant tolerability in pediatric anxiety and obsessive-compulsive disorders: a Bayesian hierarchical modeling meta-analysis","volume":"59","author":"Mills","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.001_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijchp.2015.07.003","article-title":"Predictors of response to cognitive behaviour therapy for obsessive-compulsive disorder","volume":"15","author":"Kyrios","year":"2015","journal-title":"Int J Clin Health Psychol"},{"key":"10.1016\/j.jaac.2025.01.001_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jad.2022.11.007","article-title":"Efficacy of remotely-delivered cognitive behavioural therapy for obsessive-compulsive disorder: an updated meta-analysis of randomised controlled trials","volume":"322","author":"Salazar de Pablo","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jaac.2025.01.001_bib46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jad.2024.01.155","article-title":"Long-term remission rates and trajectory predictors in obsessive-compulsive disorder: Findings from a six-year naturalistic longitudinal cohort study","volume":"350","author":"Geiger","year":"2024","journal-title":"J Affect Disord"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.001_bib47","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.comppsych.2014.04.010","article-title":"Long-term course of pediatric obsessive-compulsive disorder: 3 years of prospective follow-up","volume":"55","author":"Mancebo","year":"2014","journal-title":"Compr Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.001_bib48","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r13085","article-title":"Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide","volume":"81","author":"Fawcett","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.001_bib49","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.euroneuro.2014.02.006","article-title":"Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia\u2014an individual patient data meta-analysis","volume":"24","author":"Mattila","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.001_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.janxdis.2009.11.004","article-title":"Minority participation in randomized controlled trials for obsessive-compulsive disorder","volume":"24","author":"Williams","year":"2010","journal-title":"J Anxiety Disord"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.001_bib51","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1192\/bjp.bp.114.154062","article-title":"Ethnic inequalities in the use of secondary and tertiary mental health services among patients with obsessive-compulsive disorder","volume":"207","author":"Fern\u00e1ndez de la Cruz","year":"2015","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.001_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2020.102229","article-title":"Ethnicity moderates outcome in family focused treatment for pediatric obsessive compulsive disorder","volume":"73","author":"Peris","year":"2020","journal-title":"J Anxiety Disord"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.001_bib53","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/MLR.0b013e3181271462","article-title":"Ethnicity\/race and outcome in the treatment of depression: results from STAR\u2217D","volume":"45","author":"Lesser","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.jaac.2025.01.001_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.copsyc.2015.10.009","article-title":"Cultural influences in mental health treatment","volume":"8","author":"Huang","year":"2016","journal-title":"Curr Opin Psychol"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.001_bib55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00004583-200110000-00011","article-title":"Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder","volume":"40","author":"Cook","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.001_bib56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.euroneuro.2006.11.005","article-title":"Escitalopram prevents relapse of obsessive-compulsive disorder","volume":"17","author":"Fineberg","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2022-300630","article-title":"Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis","volume":"26","author":"Motta","year":"2023","journal-title":"BMJ Ment Health"},{"issue":"1572","key":"10.1016\/j.jaac.2025.01.001_bib58","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1098\/rstb.2010.0384","article-title":"The placebo response in clinical trials: more questions than answers","volume":"366","author":"Enck","year":"2011","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.001_bib59","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1740774510367916","article-title":"Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity","volume":"7","author":"Colagiuri","year":"2010","journal-title":"Clin Trials"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.001_bib60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaac.2019.08.480","article-title":"Systematic review and meta-analysis: cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents","volume":"59","author":"Uhre","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.001_bib61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/cap.2023.0018","article-title":"What is the added benefit of combining cognitive behavioral therapy and selective serotonin reuptake inhibitors in youth with obsessive compulsive disorder? A Bayesian hierarchical modeling meta-analysis","volume":"33","author":"Mendez","year":"2023","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2025.01.001_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychires.2022.01.057","article-title":"Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: a network meta-analysis","volume":"148","author":"Tao","year":"2022","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jaac.2025.01.001_bib63","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework","volume":"371","author":"Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.001_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856725000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856725000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:50:02Z","timestamp":1762314602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856725000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0890856725000024"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2025.01.001","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review and Meta-Analysis of Individual Participant Data: Randomized, Placebo-Controlled Trials of Selective Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2025.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92025 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}